Mylan To Lose Hostile Takeover Of Perrigo

  • Shares of Mylan NV MYL surged higher by 10 percent early Friday morning while shares of Perrigo Company plc Ordinary Shares PRGO lost more than 11 percent.
  • Mylan's acquisition of Perrigo was contingent on at least 50 percent of Perrigo's shareholders tendering their stock.
  • The offer expired Friday morning, but The Wall Street Journal reported that Mylan is set to lose in its $26 billion hostile takeover.

Mylan has spent the better part of the past seven months convincing Perrigo investors to tender their stock as part of a $26 billion hostile takeover, as at least 50 percent of Perrigo shareholders were needed to tender their stock for an acquisition to proceed.

The Wall Street Journal, citing "people familiar with the matter," reported that Mylan's efforts have fallen short.

The tender offer expired Friday at 8:00 a.m. ET, but most institutional investors needed to complete the tender by Thursday evening to be counted by the national stock clearinghouse.

Shares of Perrigo plunged more than 11 percent during Friday's pre-market session, while Mylan's stock traded higher by more than 10 percent.

WSJ added that the outcome is most certainly "rare" in what has proven to be "one of the bitterest takeover battles in decades." The publication also stated that the past seven months has been characterized as nearly a year of "fevered, at times contentious" deal-making.

Now that Perrigo has apparently fought off a hostile takeover, it will continue operating as a stand-alone entity. Last month the company introduced a series of cost cutting measures and a stock buyback program that should appease investors.

Posted In: NewsHealth CareLegalM&AGeneralMylan Acquisitionpharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...